Abstract: A sterile pharmaceutical composition for parenteral administration of propofol, said composition comprising propofol, optionally albumin, and less than about 10% by weight solvent for propofol, wherein said composition is stored in a container having a closure wherein said closure is inert to propofol.
Type:
Grant
Filed:
July 10, 2003
Date of Patent:
July 2, 2013
Assignee:
APP Pharmaceuticals LLC
Inventors:
Neil P. Desai, Andrew Yang, Sherry Xiaopei Ci
Abstract: The invention provides among other things a stable, sterile pharmaceutical formulation comprising lyophilized azithromycin and ethanol. The invention also provides a method of producing a stable, sterile pharmaceutical product comprising lyophilized azithromycin. The invention also provides a pharmaceutical dosage form comprising the pharmaceutical formulation, as well as a method of treating a disease in a patient comprising administering a solution of the pharmaceutical formulation to a patient.
Type:
Grant
Filed:
March 17, 2004
Date of Patent:
December 23, 2008
Assignee:
APP Pharmaceuticals, LLC
Inventors:
Byung Ho Woo, K. Keith Kwok, Kang Yong Yang
Abstract: The invention provides among other things a stable, sterile pharmaceutical formulation comprising lyophilized azithromycin and ethanol. The invention also provides a method of producing a stable, sterile pharmaceutical product comprising lyophilized azithromycin. The invention also provides a pharmaceutical dosage form comprising the pharmaceutical formulation, as well as a method of treating a disease in a patient comprising administering a solution of the pharmaceutical formulation to a patient.
Type:
Application
Filed:
March 27, 2008
Publication date:
September 11, 2008
Applicant:
APP Pharmaceuticals, LLC.
Inventors:
Byung Ho Woo, K. Keith Kwok, Kang Yong Yang
Abstract: The invention provides among other things a stable, sterile pharmaceutical formulation comprising lyophilized tobramycin, wherein the lyophilized tobramycin is in the form of a free-flowing powder. The invention also provides a method of producing a stable, sterile pharmaceutical product comprising lyophilized tobramycin. The invention also provides a pharmaceutical dosage form comprising the pharmaceutical formulation, as well as a method of treating a disease in a patient comprising administering a solution of the pharmaceutical formulation to a patient.